GeoVax VP granted 17,600 stock options

GeoVax Labs, Inc. granted stock options to a senior executive.

Rhea-AI Filing Summary

GeoVax Labs, Inc. granted stock options to a senior executive. VP of Business Development John W. Sharkey received an award of 17,600 stock options for common stock on June 17, 2026 at an exercise price of $1.18 per share.

The options vest in three equal annual installments on the first three anniversaries of the grant date and expire on June 17, 2036. This is a compensation-related grant, not an open-market purchase or sale, and leaves Sharkey holding 17,600 options directly after the transaction.

Insider Trade Summary

Grant/Award: 17,600 shares

Grant/Award 1 txn

Insider Sharkey John W.

Role VP, Business Development

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	17,600	$0.00	$0.00

Holdings After Transaction: Stock Option — 17,600 contracts (Direct)

Footnotes (1)

1. F1. Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant.

Key Figures

Options granted: 17,600 options Exercise price: $1.18 per share Expiration date: June 17, 2036 +1 more

4 metrics

Options granted 17,600 options Stock option award to VP on June 17, 2026

Exercise price $1.18 per share Conversion or exercise price of granted options

Expiration date June 17, 2036 Option term for this grant

Post-grant holdings 17,600 options Total options held directly following this transaction

Key Terms

Stock Option, grant/award acquisition, exercise price, expiration date, +1 more

5 terms

Stock Option financial

"Stock Option becomes exercisable in three equal annual installments"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

grant/award acquisition financial

"transaction_action: grant/award acquisition for 17,600 options"

exercise price financial

"conversion_or_exercise_price of $1.18 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date set to June 17, 2036 for the options"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

vesting financial

"becomes exercisable in three equal annual installments"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did GeoVax Labs (GOVX) report in this Form 4 filing?

GeoVax Labs reported that VP of Business Development John W. Sharkey received a grant of 17,600 stock options. These options are for GeoVax common stock, have an exercise price of $1.18 per share, and represent a compensation-related award, not a market trade.

How many GeoVax (GOVX) stock options were granted to John W. Sharkey?

John W. Sharkey was granted 17,600 stock options for GeoVax common stock. All 17,600 options are held directly after the transaction, giving him the right to buy the same number of shares if he chooses to exercise at the stated price.

What is the exercise price and expiration date of the new GeoVax options?

The new GeoVax stock options have an exercise price of $1.18 per share and expire on June 17, 2036. This means Sharkey can choose to buy shares at $1.18 any time before that expiration, subject to the vesting schedule.

How do the GeoVax (GOVX) options granted to Sharkey vest over time?

The stock options vest in three equal annual installments on the first three anniversaries of the June 17, 2026 grant date. This staggered vesting encourages longer-term alignment, as Sharkey must remain over time to gain full access to all granted options.

Was this GeoVax Form 4 transaction a market buy or sell of GOVX shares?

No, the Form 4 shows a grant or award acquisition of stock options, not a market buy or sell. The transaction code is “A,” indicating a compensation-related award, so no open-market purchase or sale of GeoVax common stock occurred in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/22/2026 - 04:19 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sharkey John W.

(Last) (First) (Middle)

1955 LAKE PARK DRIVE

SUITE 300

(Street)

SMYRNA GEORGIA 30080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GeoVax Labs, Inc. [ GOVX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP, Business Development

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$1.18	06/17/2026		A		17,600		(1)	06/17/2036	Common Stock	17,600	$0	17,600	D

Explanation of Responses:

1. Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant.

	/s/ John W. Sharkey	06/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)